It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put Under The Microscope [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Milestone Pharmaceuticals Inc. - Common Shares (MIST)
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Total compensation is 130% above industry average Milestone Pharmaceuticals' EPS declined by 9.8% over the past three years while total shareholder loss over the past three years was 73% Shareholders will probably not be too impressed with the underwhelming results at Milestone Pharmaceuticals Inc. NASDAQ:MIST ) recently. At the upcoming AGM on 13th of June, shareholders can hear from the board including their plans for turning around performance. It would also be an opportunity for shareholders to influence management through voting on company resolutions such as executive remuneration, which could impact the firm significantly. We present the case why we think CEO compensation is out of sync with company performance. Check out our latest analysis for Milestone Pharmaceuticals How Does Total Compensation For Joe Oliveto Compare With Other Companies In The Industry? Our data indicates that Milestone Pharmaceuticals Inc. has a market capitalization of US$98m, and total annua
Show less
Read more
Impact Snapshot
Event Time:
MIST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MIST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MIST alerts
High impacting Milestone Pharmaceuticals Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MIST
News
- Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024 [Yahoo! Finance]Yahoo! Finance
- Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024GlobeNewswire
- Paroxysmal Supraventricular Tachycardia Market to Show Immense Growth During the Study Period (2020-2034) | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare ConferenceGlobeNewswire
MIST
Earnings
- 5/13/24 - Beat
MIST
Sec Filings
- 5/29/24 - Form 8-K
- 5/13/24 - Form 8-K
- 5/13/24 - Form 10-Q
- MIST's page on the SEC website